Results 131 to 140 of about 588,306 (330)
Abstracts from the Translational Reproductive Biology and Clinical Reproductive Endocrinology Conference held Novembrer 17–20, 2016 [PDF]
Mahnaz Motamedi +38 more
openalex +1 more source
ABSTRACT Objective Restrictive eating disorders (EDs), including anorexia nervosa (AN) and atypical AN (Atyp‐AN), are often associated with cognitive rigidity that can impede treatment. The dorsolateral prefrontal cortex (dlPFC) plays a central role in cognitive control, but it remains unclear whether its activation during cognitive flexibility will ...
Adrienne L. Romer +19 more
wiley +1 more source
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM [PDF]
E. P. McCULLAGH
openalex +3 more sources
Bibliography at end of most of the chapters. ; Mode of access: Internet.
openaire +1 more source
Implementation and Evaluation of Clinical Pharmacy Services on Diabetes Care in an Endocrinology Clinic [PDF]
K Fukunaga, Candace Tan
openalex +1 more source
Abstract Aims Blood levels of N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) may be modified by low renal clearance and anaemia. The aim of this study was to investigate the impact of the blood NT‐proBNP level on cardiovascular and renal outcomes in patients with these two manifestations.
Hiroshi Nishi +4 more
wiley +1 more source
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger +15 more
wiley +1 more source
Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients
Wiebke Arlt +1 more
doaj +1 more source
An invisible hand has guided clinical endocrinology toward an unexpected future. [PDF]
Trimarchi F.
europepmc +1 more source
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao +27 more
wiley +1 more source

